Structural and degradation characteristics of an innovative porous PLGA/TCP scaffold incorporated with bioactive molecular icaritin

Biomedical Materials

Volumn 5, Issue 5, 2010, Pages

  Xie, Xin Hui ^a   Wang, Xin Luan ^a   Zhang, Ge ^a   He, Yi Xin ^a   Wang, Xiao Hong ^b   Liu, Zhong ^a   He, Kai ^b   Peng, Jiang ^a,c   Leng, Yang ^d   Qin, Ling ^a,e  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b TSINGHUA UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^e SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; BIOMATERIALS; BIOMECHANICS; CALCIUM; COMPOSITE MATERIALS; COMPUTER CONTROL SYSTEMS; CYTOLOGY; DEGRADATION; LACTIC ACID; MECHANICAL PROPERTIES; MEDICAL APPLICATIONS; ORGANIC POLYMERS; SURFACE MORPHOLOGY; SURFACES;

ACID CONCENTRATIONS; BONE REPAIR; CELL MIGRATION; COMPOSITE SCAFFOLDS; CONTROLLED RELEASE; DEGRADATION CHARACTERISTICS; FOUR-GROUP; GLYCOLIDE; HIGH CONCENTRATION; IN-VITRO; IN-VIVO; L-LACTIDE; MICROPORES; NUMBER AND SIZE; OSTEOCONDUCTIVE; POROUS COMPOSITE SCAFFOLD; POROUS COMPOSITES; POROUS MORPHOLOGY; POROUS SCAFFOLD; POROUS STRUCTURES; PRINTING MACHINES; RELEASE PATTERN; SCAFFOLD DEGRADATION; SCAFFOLD MATERIALS; SEM; SLOW RELEASE; TRI-CALCIUM PHOSPHATES;

SCAFFOLDS;

CALCIUM; CALCIUM PHOSPHATE; ICARITIN; LACTIC ACID; PHYTOESTROGEN; POLYGLACTIN; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; BIOMATERIAL; FLAVONOID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYMER;

ACIDITY; ARTICLE; CHEMICAL ANALYSIS; COMPOSITE MATERIAL; CONTROLLED DRUG RELEASE; DEGRADATION; MATERIALS TESTING; MECHANICS; STRUCTURE ANALYSIS; BIOMECHANICS; BONE; CHEMISTRY; COMPARATIVE STUDY; COMPRESSIVE STRENGTH; CULTURE MEDIUM; PH; POROSITY; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TEMPERATURE; TIME;

BIOCOMPATIBLE MATERIALS; BIOMECHANICS; BONE AND BONES; CALCIUM; CALCIUM PHOSPHATES; COMPRESSIVE STRENGTH; CULTURE MEDIA; FLAVONOIDS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; POLYGLYCOLIC ACID; POLYMERS; POROSITY; SURFACE PROPERTIES; TEMPERATURE; TIME FACTORS; TISSUE SCAFFOLDS;

EID: 78649311315     PISSN: 17486041     EISSN: 1748605X     Source Type: Journal    
DOI: 10.1088/1748-6041/5/5/054109     Document Type: Article

References (55)

1. Langer R and Vacanti J P 1993 Tissue engineering Science 260 920-6
2. Hollister S J 2005 Porous scaffold design for tissue engineering Nat. Mater. 4 518-24
3. Place E S, Evans N D and Stevens M M 2009 Complexity in biomaterials for tissue engineering Nat. Mater. 8 457-70
4. Griffith L G and Naughton G 2002 Tissue engineering - current challenges and expanding opportunities Science 295 1009-14
5. Hench L L and Polak J M 2002 Third-generation biomedical materials Science 295 1014-7
6. Ge Z, Tian X, Heng B C, Fan V, Yeo J F and Cao T 2009 Histological evaluation of osteogenesis of 3D-printed poly-lactic-co-glycolic acid (PLGA) scaffolds in a rabbit model Biomed. Mater. 4 021001
7. Liu G, Zhao L, Cui L, Liu W and Cao Y 2007 Tissue-engineered bone formation using human bone marrow stromal cells and novel beta-tricalcium phosphate Biomed. Mater. 2 78-86 (Pubitemid 46795266)
8. Yu D, Li Q, Mu X, Chang T and Xiong Z 2008 Bone regeneration of critical calvarial defect in goat model by PLGA/TCP/rhBMP-2 scaffolds prepared by low-temperature rapid-prototyping technology Int. J. Oral Maxillofac. Surg. 37 929-34
9. Hao W, Hu Y Y, Wei Y Y, Pang L, Lv R, Bai J P, Xiong Z and Jiang M 2008 Collagen I gel can facilitate homogenous bone formation of adipose-derived stem cells in PLGA-beta-TCP scaffold Cells Tissues Organs 187 89-102
10. He K, Wang X L, Kumta S M, Qin L, Yan Y N, Zhang R J and Wang X H 2009 Fabrication of a two-level tumor bone repair biomaterial based on a rapid prototyping technique Biofabrication 1 025003 (7pp)
11. Ehrenfried L M, Patel M H and Cameron R E 2008 The effect of tricalcium phosphate (TCP) addition on the degradation of polylactide-co-glycolide (PLGA) J. Mater. Sci., Mater. Med. 19 459-66
12. Sherwood J K, Riley S L, Palazzolo R, Brown S C, Monkhouse D C, Coates M, Griffith L G, Landeen L K and Ratcliffe A 2002 A three-dimensional osteochondral composite scaffold for articular cartilage repair Biomaterials 23 4739-51
13. Fan H, Hu Y, Zhang C, Li X, Lv R, Qin L and Zhu R 2006 Cartilage regeneration using mesenchymal stem cells and a PLGA-gelatin/chondroitin/ hyaluronate hybrid scaffold Biomaterials 27 4573-80
14. Hungerford D S 2007 Treatment of osteonecrosis of the femoral head: everything's new J. Arthroplasty 22 4 Suppl. 1 91-4
15. Nishida J and Shimamura T 2008 Methods of reconstruction for bone defect after tumor excision: a review of alternatives Med. Sci. Monit. 14 RA107-13 http://www.ncbi.nlm.nih.gov/pubmed/18668007?dopt=Citation
16. Levin L S 2006 Vascularized fibula graft for the traumatically induced long-bone defect J. Am. Acad. Orthop. Surg. 14 S175-6 http://www.ncbi.nlm.nih. gov/pubmed/17003193?dopt=Citation
17. Zhang G et al 2009 Continuous occurrence of both insufficient neovascularization and elevated vascular permeability in rabbit proximal femur during inadequate repair of steroid-associated osteonecrotic lesions Arthritis Rheum. 60 2966-77
18. Lieberman J R, Conduah A and Urist M R 2004 Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein Clin. Orthop Relat. Res. 429 139-45
19. Tang T T, Lu B, Yue B, Xie X H, Xie Y Z, Dai K R, Lu J X and Lou J R 2007 Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue-engineered bone in goats J. Bone Joint Surg. Br. 89 127-9
20. Mont M A, Jones L C, Einhorn T A, Hungerford D S and Reddi A H 1998 Osteonecrosis of the femoral head: potential treatment with growth and differentiation factors Clin. Orthop Relat. Res. (355 Suppl.) S314-35
21. Fan H, Hu Y, Li X,Wu H, Lv R, Bai J,Wang J and Qin L 2006 Ectopic cartilage formation induced by mesenchymal stem cells on porous gelatin-chondroitin-hyaluronate scaffold containing microspheres loaded with TGF-beta1 Int. J. Artif. Organs 29 602-11 http://www.ncbi.nlm.nih.gov/pubmed/ 16841290?dopt=Citation
22. Fan H, Zhang C, Li J, Bi L, Qin L, Wu H and Hu Y 2008 Gelatin microspheres containing TGF-beta3 enhance the chondrogenesis of mesenchymal stem cells in modified pellet culture Biomacromolecules 9 927-34
23. Laflamme C and Rouabhia M 2008 Effect of BMP-2 and BMP-7 homodimers and a mixture of BMP-2/BMP-7 homodimers on osteoblast adhesion and growth following culture on a collagen scaffold Biomed. Mater. 3 015008 (Pubitemid 351366833)
24. Huang J, Yuan L, Wang X, Zhang T L and Wang K 2007 Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro Life Sci. 81 832-40
25. Zhang G et al 2009 A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner Bone 44 345-56
26. Qin L, Zhang G, Sheng H, Wang X L, Wang Y X, Yeung K W, Griffith J F, Li Z R, Leung K S and Yao X S 2008 Phytoestrogenic compounds for prevention of steroid-associated osteonecrosis J. Musculoskelet. Neuronal Interact. 8 18-21 http://www.ncbi.nlm.nih.gov/pubmed/18398255?dopt=Citation
27. Wang X L, Zhang G, Xie X H, Yao X S and Qin L 2008 Antagonistic estrogen receptor beta signaling required in promoting periosteum bone formation and inhibiting osteoclastic bone resorption by Icaritin - a novel synthetic small molecule Bone 43 Suppl. 1 S115
28. Zhang G et al 2009 Constitutional flavonoids derived from epimedium dose-dependently reduce incidence of steroid-associated osteonecrosis not via direct action by themselves on potential cellular targets PLoS One 4 e6419
29. Zhang G, Qin L, Sheng H, Yeung K W, Yeung H Y, Cheung W H, Griffith J, Chan C W, Lee K M and Leung K S 2007 Epimedium-derived phytoestrogen exert beneficial effect on preventing steroid-associated osteonecrosis in rabbits with inhibition of both thrombosis and lipid-deposition Bone 40 685-92
30. Peng S L, Zhang G, He Y X, Wang X L, Leung P C, Leung K S and Qin L 2009 Epimedium-derived flavonoids promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while exerting an anabolic effect on osteoporotic bone Bone 45 534-44
31. Wang X, Yan Y and Zhang R 2007 Rapid prototyping as a tool for manufacturing bioartificial livers Trends Biotechnol. 25 505-13
32. Wang X, Ma J, Wang Y and He B 2001 Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements Biomaterials 22 2247-55
33. Wang X et al 2006 Generation of three-dimensional hepatocyte/gelatin structures with rapid prototyping system Tissue Eng. 12 83-90
34. Shen P, Wong S P and Yong E L 2007 Sensitive and rapid method to quantify icaritin and desmethylicaritin in human serum using gas chromatography-mass spectrometry J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 857 47-52
35. Zein I, Hutmacher D W, Tan K C and Teoh S H 2002 Fused deposition modeling of novel scaffold architectures for tissue engineering applications Biomaterials 23 1169-85
36. Lu L, Peter S J, Lyman M D, Lai H L, Leite S M, Tamada J A, Uyama S, Vacanti J P, Langer R and Mikos A G 2000 In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams Biomaterials 21 1837-45
37. Yang F, Cui W J, Xiong Z, Liu L, Bei J and Wang S 2006 Poly(L, L-lactide-co-glycolide)/tricalcium phosphate composite scaffold and its various changes during degradation in vitro Polym. Degrad. Stab. 91 3065-73
38. Yeung H Y, Qin L, Lee K M, Zhang M, Leung K S and Cheng C Y 2005 Novel approach for quantification of porosity for biomaterial implants using microcomputed tomography (microCT) J. Biomed. Mater. Res B 75 234-42
39. Siu W S, Qin L, Cheung W H and Leung K S 2004 A study of trabecular bones in ovariectomized goats with micro-computed tomography and peripheral quantitative computed tomography Bone 35 21-6
40. Leung K S, Siu W S, Li S F, Qin L, Cheung W H, Tam K F and Lui P P 2006 An in vitro optimized injectable calcium phosphate cement for augmenting screw fixation in osteopenic goats J. Biomed. Mater. Res B Appl. Biomater. 78 153-60 http://www.ncbi.nlm.nih.gov/pubmed/16292768?dopt=Citation
41. Qin L and Zhang M 2005 Mechanical testing for bone specimens Current Topics of Bone Biology ed H W Deng and Y Z Liu (Singapore: World Scientific) pp 177-212 http://books.google.com/books?hl=zh-CN&lr=&id= 3hS7hV9j4BAC&oi=fnd&pg=PA177&dq= Mechanical+testing+for+bone+specimens&ots=u1F3eJTCy5&sig= xECEnwlwbDtipN7eZwt0vB3c5Kg#v=onepage&q= Mechanical%20testing%20for%20bone%20specimens&f=false
42. Qin L, Chan K, B R and Guo X 1997 Bone mineral content measurement using QCT for predicting the cortical and trabecular bone mechanical properties Chin. J. Orthop. 17 66-70
43. Kim M S, Ahn H H, Shin Y N, Cho M H, Khang G and Lee H B 2007 An in vivo study of the host tissue response to subcutaneous implantation of PLGA- and/or porcine small intestinal submucosa-based scaffolds Biomaterials 28 5137-43
44. Yang Y, Zhao Y, Tang G, Li H, Yuan X and Fan Y 2008 In vitro degradation of porous poly(L-lactide-co-glycolide)/β-tricalcium phosphate (PLGA/β-TCP) scaffolds under dynamic and static conditions Polym. Degrad. Stab. 93 1838-45
45. Chen V J and Ma P X 2006 The effect of surface area on the degradation rate of nano-fibrous poly(L-lactic acid) foams Biomaterials 27 3708-15
46. Zolnik BS, Leary P E and Burgess D J 2006 Elevated temperature accelerated release testing of PLGA microspheres J. Control. Release 112 293-300
47. Loher S, Reboul V, Brunner T, Simonet M, Dora C and Neuenschwander P 2006 Improved degradation and bioactivity of amorphous aerosol derived tricalcium phosphate nanoparticles in poly(lactide-co-glycolide) Nanotechnology 17 2054-61
48. Ara M, Watanabe M and Imai Y 2002 Effect of blending calcium compounds on hydrolytic degradation of poly(DL-lactic acid-co-glycolic acid) Biomaterials 23 2479-83 (Pubitemid 34288489)
49. Butler M J and Sefton M V 2007 Poly(butyl methacrylate-co-methacrylic acid) tissue engineering scaffold with pro-angiogenic potential in vivo J. Biomed. Mater. Res. A 82 265-73 http://www.ncbi.nlm.nih.gov/pubmed/17530634? dopt=Citation
50. Henry J A, Burugapalli K, Neuenschwander P and Pandit A 2009 Structural variants of biodegradable polyesterurethane in vivo evoke a cellular and angiogenic response that is dictated by architecture Acta Biomater. 5 29-42
51. Karageorgiou V and Kaplan D 2005 Porosity of 3D biomaterial scaffolds and osteogenesis Biomaterials 26 5474-91
52. Buehler M J and Yung Y C 2009 Deformation and failure of protein materials in physiologically extreme conditions and disease Nat. Mater. 8 175-88
53. Jones J R, Tsigkou O, Coates E E, Stevens M M, Polak J M and Hench L L 2007 Extracellular matrix formation and mineralization on a phosphate-free porous bioactive glass scaffold using primary human osteoblast (HOB) cells Biomaterials 28 1653-63
54. Lin C Y, Schek R M, Mistry A S, Shi X, Mikos A G, Krebsbach P H and Hollister S J 2005 Functional bone engineering using ex vivo gene therapy and topologyoptimized, biodegradable polymer composite scaffolds Tissue Eng. 11 1589-98
55. Cancedda R, Giannoni P and Mastrogiacomo M 2007 A tissue engineering approach to bone repair in large animal models and in clinical practice Biomaterials 28 4240-50